TBIO : Summary for TRANSGENOMIC INC COM USD0.01(PO - Yahoo Finance

U.S. Markets close in 3 hrs 40 mins

Transgenomic, Inc. (TBIO)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.44-0.03 (-6.32%)
As of 12:02PM EDT. Market open.
People also watch
RNVABIOCETRMIDXGPULM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.47
Open0.45
Bid0.00 x
Ask0.00 x
Day's Range0.43 - 0.46
52 Week Range0.15 - 1.59
Volume32,274
Avg. Volume644,620
Market Cap11.96M
Beta-0.51
PE Ratio (TTM)-1.26
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire4 days ago

    Precipio Renews its Exclusive Agreement with Yale School of Medicine for an Additional Five Years

    NEW HAVEN, CT / ACCESSWIRE / April 20, 2017 / Precipio Diagnostics, a company harnessing the experience, knowledge and expertise of academic-level pathology to deliver diagnostic accuracy to physicians ...

  • Business Wire7 days ago

    Transgenomic Closes Bridge Financing

    Transgenomic, Inc. today reported that it has received $1.15 million in proceeds from a note bridge financing. The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC, which is expected to close during the second quarter of 2017.

  • Transgenomic, Inc. :TBIO-US: Earnings Analysis: 2016 By the Numbers : April 14, 2017
    Capital Cube10 days ago

    Transgenomic, Inc. :TBIO-US: Earnings Analysis: 2016 By the Numbers : April 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Transgenomic, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Transgenomic, Inc. – Agilent Technologies, Inc. (A-US) that have also reported for this period. Highlights Gross margins narrowed from -0.57% to -13.17% compared to the same period last year, ... Read more (Read more...)